Abiopharma

New Form 25-NSE - Regulus Therapeutics Inc. Filed: 2025-06-25 AccNo: 0001354457-25-000571 Size: 3 KB

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device

ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

Vistagen Appoints Elissa Cote as Chief Corporate Development Officer

Eyenovia Announces Co-Branded Validator with Kinetiq

New Form 8-K - Tivic Health Systems, Inc. Filed: 2025-06-25 AccNo: 0000950170-25-089741 Size: 208 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology

Hepion Pharmaceuticals Successfully Completes Application to the OTCQB

New Form 8-K - Envoy Medical, Inc. Filed: 2025-06-25 AccNo: 0001213900-25-057481 Size: 303 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia

Hepion Pharmaceuticals Successfully Completes Application to the OTCQB

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply

Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development